PLGA Nanoparticles Codelivering siRNAs against Programmed Cell Death Protein-1 and Its Ligand Gene for Suppression of Colon Tumor Growth-Reference-Cited by-同舟云学术

PLGA Nanoparticles Codelivering siRNAs against Programmed Cell Death Protein-1 and Its Ligand Gene for Suppression of Colon Tumor Growth

Published:2019-10-25 Issue:12 Volume:16 Page:4940-4953
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Kwak Seo Young¹,Lee Seonmin,Han Hee Dong²,Chang Suhwan³,Kim Kyu-pyo,Ahn Hyung Jun¹^ORCID

Affiliation:

1. Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, South Korea

2. Department of Immunology, School of Medicine, Konkuk University, Chungju 27478, South Korea

3. Department of Biomedical Sciences, Department of Physiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 138-736, South Korea

Funder

National Research Foundation of Korea

Korea Institute of Science and Technology

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.9b00826

Reference52 articles.

1. Immune Escape Mechanisms as a Guide for Cancer Immunotherapy

2. Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies

3. Immune Checkpoint Blockade in Cancer Therapy

4. Clinical blockade of PD1 and LAG3 — potential mechanisms of action

5. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune‐related adverse events of antibody‐based biological medicines in cancer therapy;Journal of Cellular and Molecular Medicine;2024-07

2. Enhancing cancer immunotherapy: Exploring strategies to target the PD-1/PD-L1 axis and analyzing the associated patent, regulatory, and clinical trial landscape;European Journal of Pharmaceutics and Biopharmaceutics;2024-07

3. Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade;Advanced Drug Delivery Reviews;2024-06

4. Recent progress, perspectives, and issues of engineered PD-L1 regulation nano-system to better cure tumor: A review;International Journal of Biological Macromolecules;2024-01

5. Novel technologies for applying immune checkpoint blockers;International Review of Cell and Molecular Biology;2024